×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LPCN – lipocine inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LPCN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
08:12 am
lpcn
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session [Yahoo! Finance]
Medium
Report
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session [Yahoo! Finance]
11/18
08:00 am
lpcn
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session
High
Report
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session
11/7
08:00 am
lpcn
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024
Medium
Report
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024
10/31
08:00 am
lpcn
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea
Medium
Report
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea
10/14
11:09 pm
lpcn
Lipocine Inc. (NASDAQ: LPCN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
10/10
08:00 am
lpcn
Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results
Low
Report
Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results
10/8
08:00 am
lpcn
Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries
Low
Report
Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries
10/2
08:00 am
lpcn
Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024
Low
Report
Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
09:45 am
lpcn
Form 8-K Lipocine Inc. For: Nov 18
Low
Report
Form 8-K Lipocine Inc. For: Nov 18
11/7
09:35 am
lpcn
Form 8-K Lipocine Inc. For: Nov 07
Medium
Report
Form 8-K Lipocine Inc. For: Nov 07
11/7
06:09 am
lpcn
Form 10-Q Lipocine Inc. For: Sep 30
Medium
Report
Form 10-Q Lipocine Inc. For: Sep 30
11/5
04:38 pm
lpcn
Form 8-K Lipocine Inc. For: Nov 05
Medium
Report
Form 8-K Lipocine Inc. For: Nov 05
10/31
09:35 am
lpcn
Form 8-K Lipocine Inc. For: Oct 28
Low
Report
Form 8-K Lipocine Inc. For: Oct 28
10/23
06:01 am
lpcn
Form 8-K Lipocine Inc. For: Oct 22
Medium
Report
Form 8-K Lipocine Inc. For: Oct 22
10/16
04:06 pm
lpcn
Form 8-K Lipocine Inc. For: Oct 16
Low
Report
Form 8-K Lipocine Inc. For: Oct 16
10/10
06:05 am
lpcn
Form 8-K Lipocine Inc. For: Oct 10
Low
Report
Form 8-K Lipocine Inc. For: Oct 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/24
Lipocine Announces Regulatory Path Forward for TLANDO™ Resubmission
65.6%
2/25 Lipocine Announces $6 Million Registered Direct Offering Priced At-The-Market 13.8%
1/1 LIPOCINE EQUITY LOSS ALERT: ROSEN, A LEADING LAW FIRM, Reminds Lipocine Inc. Investors of Important January 14th Deadline in Securities Class Action - LPCN 8.9%
1/10 Form 8-K Lipocine Inc. For: Jan 10 8.0%
5/14 Lipocine Announces TLANDO™ NDA PDUFA Action Date of November 9, 2019 7.2%
4/10 Investors Who Bought Lipocine (NASDAQ:LPCN) Shares Five Years Ago Are Now Down 94% [Yahoo! Finance News] 6.8%
4/17 Form 8-K Lipocine Inc. For: Apr 17 6.2%
3/4 Lipocine Announces TLANDO™ PDUFA Date of August 28, 2020 6.1%
8/7 Q2/2019 6/30/2019 EPS -0.140 ZacksConsensus -0.220 ActVsEst 0.080 - Beat 5.6%
2/5 Form 8-K Lipocine Inc. For: Feb 05 4.7%
2/25 Lipocine Announces $6 Million Registered Direct Offering Priced At-The-Market 13.8%
1/1 LIPOCINE EQUITY LOSS ALERT: ROSEN, A LEADING LAW FIRM, Reminds Lipocine Inc. Investors of Important January 14th Deadline in Securities Class Action - LPCN 8.9%
1/10 Form 8-K Lipocine Inc. For: Jan 10 8.0%
5/14 Lipocine Announces TLANDO™ NDA PDUFA Action Date of November 9, 2019 7.2%
4/10 Investors Who Bought Lipocine (NASDAQ:LPCN) Shares Five Years Ago Are Now Down 94% [Yahoo! Finance News] 6.8%
4/17 Form 8-K Lipocine Inc. For: Apr 17 6.2%
3/4 Lipocine Announces TLANDO™ PDUFA Date of August 28, 2020 6.1%
8/7 Q2/2019 6/30/2019 EPS -0.140 ZacksConsensus -0.220 ActVsEst 0.080 - Beat 5.6%
2/5 Form 8-K Lipocine Inc. For: Feb 05 4.7%
TOP News Decliners
11/11
Lipocine Receives Complete Response Letter for TLANDO™ from U.S. FDA
-72.0%
11/13 Lipocine Announces Launch Of Public Offering Of Common Stock And Warrants -40.9%
3/13 Form 10-K Lipocine Inc. For: Dec 31 -18.9%
7/23 Form 8-K Lipocine Inc. For: Jul 23 -17.8%
11/12 Form 8-K Lipocine Inc. For: Nov 12 -14.5%
4/1 Form 8-K Lipocine Inc. For: Apr 01 -11.8%
4/21 Form 8-K Lipocine Inc. For: Apr 21 -10.2%
11/12 Form 8-K Lipocine Inc. For: Nov 11 -9.7%
1/13 TUESDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lipocine Inc. and Encourages Investors with Losses to Contact the Firm -8.9%
11/14 Form 424B5 Lipocine Inc. -8.5%
11/13 Lipocine Announces Launch Of Public Offering Of Common Stock And Warrants -40.9%
3/13 Form 10-K Lipocine Inc. For: Dec 31 -18.9%
7/23 Form 8-K Lipocine Inc. For: Jul 23 -17.8%
11/12 Form 8-K Lipocine Inc. For: Nov 12 -14.5%
4/1 Form 8-K Lipocine Inc. For: Apr 01 -11.8%
4/21 Form 8-K Lipocine Inc. For: Apr 21 -10.2%
11/12 Form 8-K Lipocine Inc. For: Nov 11 -9.7%
1/13 TUESDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lipocine Inc. and Encourages Investors with Losses to Contact the Firm -8.9%
11/14 Form 424B5 Lipocine Inc. -8.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: